Evidence map›Paper›PMID 36598274›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2023

Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars Compacta.

Ernest W Wang, Gregory L Brown, Mechelle M Lewis, Leslie C Jellen, Cunfeng Pu, Melinda L Johnson, Hairong Chen, Lan Kong, Guangwei Du, Xuemei Huang

Open access · bronzeAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Article
  6. Review
  7. Iron Deposition in Parkinson's Disease: A Mini-Review.Cellular and molecular neurobiology · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ernest W WangDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Gregory L BrownDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Mechelle M LewisDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Leslie C JellenDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Cunfeng PuDepartment of Pathology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Melinda L JohnsonDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Hairong ChenDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Lan KongDepartment of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Guangwei DuDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.ORCID 0000-0002-8267-0301
Xuemei HuangDepartment of Neurology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.ORCID 0000-0003-3583-5502
Pennsylvania State University · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR000127 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$17.1M
Regional Brain Manganese Accumulation and Functional Consequences in WeldersR01ES019672 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2011 to 2021
$5.9M
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological RelevanceU01NS112008 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI, KANTHASAMY, ANUMANTHA GOUNDER · 2019 to 2023
$5.5M
Multimodal MRI Markers of Nigrostriatal Pathology in Parkinson's DiseaseU01NS082151 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2012 to 2016
$4.2M
NRSA Training CoreTL1TR002016 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI THOMAS, GAIL D. · 2016 to 2025
$3.4M
Structural MRI marker(s) of Parkinson's Disease's ProgressionR01NS060722 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2009 to 2013
$2.9M
Effects of HFE H63D on Brain Mn Accumulation and NeurotoxicityF30ES030607 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WANG, ERNEST W · 2019 to 2024
$181k
The Striatum and Hippocampus: "Hubs" of White Matter Connections in Parkinson's Disease Cognitive DeclineF30AG067651 · NIA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI BROWN, GREGORY L · 2020 to 2024
$153k
NCATS NIH HHS TL1 TR002016NCATS NIH HHS TL1-TR002016NCATS NIH HHS UL1 TR000127NCATS NIH HHS UL1-TR000127NIA NIH HHS F30 AG067651NIA NIH HHS F30-AG067651NIEHS NIH HHS F30 ES030607NIEHS NIH HHS F30-ES030607NIEHS NIH HHS R01 ES019672NIEHS NIH HHS R01-ES019672NINDS NIH HHS R01 NS060722NINDS NIH HHS R01-NS060722NINDS NIH HHS U01 NS082151NINDS NIH HHS U01-NS082151NINDS NIH HHS U01 NS112008NINDS NIH HHS U01-NS112008
6 · The paper itself

Abstract

backgroundSusceptibility magnetic resonance imaging (MRI) is sensitive to iron-related changes in the substantia nigra pars compacta (SNc), the key pathologic locus of parkinsonisms. It is unclear, however, if iron deposition in the SNc is associated with its neurodegeneration.

objectiveThe objective of this study was to test whether susceptibility MRI metrics in parkinsonisms are associated with SNc neuropathologic features of dopaminergic neuron loss, gliosis, and α-synuclein and tau burden.

methodsThis retrospective study included 27 subjects with both in vivo MRI and postmortem data. Multigradient echo imaging was used to derive the apparent transverse relaxation rate (R2*) and quantitative susceptibility mapping (QSM) in the SNc. Archived midbrain slides that were stained with hematoxylin and eosin, anti-α-synuclein, and anti-tau were digitized to quantify neuromelanin-positive neuron density, glial density, and the percentages of area occupied by positive α-synuclein and tau staining. MRI-histology associations were examined using Pearson correlations and regression.

resultsTwenty-four subjects had postmortem parkinsonism diagnoses (Lewy body disorder, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration), two had only Alzheimer's neuropathology, and one exhibited only mild atrophy. Among all subjects, both R2* and QSM were associated with glial density (r ≥ 0.67; P < 0.001) and log-transformed tau burden (r ≥ 0.53; P ≤ 0.007). Multiple linear regression identified glial density and log-transformed tau as determinants for both MRI metrics (R

conclusionsR2* and QSM are associated with both glial density and tau burden, key neuropathologic features in the parkinsonism SNc. © 2023 International Parkinson and Movement Disorder Society.

Indexed as

Parkinson DiseaseParkinsonian DisordersHumansIronMagnetic Resonance ImagingPars CompactaRetrospective StudiesSubstantia NigraIrongliaparkinsonismsubstantia nigra pars compactasusceptibility MRItau

Identifiers

PMID36598274
PMCPMC10445152
OpenAlexW4313545000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.